IFP Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

IFP Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$925	Buy	181 +150	+484%	+$817	﹤0.01%	4509
2026 Q2	$163	Hold	31	–	–	﹤0.01%	4892
2026 Q1	$130	Hold	31	–	–	﹤0.01%	4702
2025 Q4	$149	Sell	31 -1	-3%	-$5	﹤0.01%	4523
2025 Q3	$162	Buy	32 +1	+3%	+$4	﹤0.01%	4437
2025 Q2	$125	Buy	31 +23	+288%	+$75	﹤0.01%	4704
2025 Q1	$22	Hold	8	–	–	﹤0.01%	4150
2024 Q4	$34	Buy	+8	New	+$30	﹤0.01%	4346
2021 Q3	–	Sell	-796	Closed	-$8K	–	3375
2021 Q2	$8K	Buy	796 +35	+5%	+$345	﹤0.01%	2280
2021 Q1	$8K	Buy	+761	New	+$10.6K	﹤0.01%	2208

Other funds holding SRTA

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Arnhold LLC New York $1.4B AUM 42.37% 1-Year Est. Return

Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return

Fifth Third Wealth Advisors Cincinnati, Ohio $3.78B AUM 26.11% 1-Year Est. Return

Seelaus Asset Management Chatham, New Jersey $136M AUM 34.83% 1-Year Est. Return

Cyndeo Wealth Partners St. Petersburg, Florida $2.21B AUM 17.29% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.72% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

IFP Advisors's SRTA Position: Q3 2026 in Review

IFP Advisors increased its Strata Critical Medical Inc (SRTA) stake by 484% in Q3 2026, buying an estimated $817 and bringing the position to 181 shares worth $925. The position accounts for ﹤0.01% of the portfolio, ranked #4509.

IFP Advisors first reported a position in SRTA in Q1 2021 and has held it in 10 quarters since. The position peaked at $8K in Q2 2021. 32 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

IFP Advisors held 181 shares of Strata Critical Medical Inc worth $925 as of Q3 2026.
IFP Advisors bought 150 Strata Critical Medical Inc shares in Q3 2026, an estimated $817.
Strata Critical Medical Inc made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4509 holding.
IFP Advisors first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 10 quarters since.
IFP Advisors's Strata Critical Medical Inc position peaked at $8K in Q2 2021.
32 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.